Latest ebit for 4DX.AX: $-100M, below the sector sector average of $2.4T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
4DMedical Limited (4DX.AX) currently reports a EBIT of $-100M as of June 2026. That compares with $-67M in the prior-year period — down 56.5% year over year. That is below the sector sector average of $2.4T. Use the charts on this page to explore 4DMedical Limited's EBIT history and peer comparisons.
4DMedical Limited's EBIT decreased from $-67M to $-100M — a 56.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
4DMedical Limited's EBIT of $-100M is lower than the its sector sector average of $2.4T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
4DMedical Limited reported $-100M in EBIT as of June 2026. That compares with $-67M in the prior-year period — down 56.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-100M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.4T. From there, open related valuation or income-statement pages for 4DMedical Limited, and consider following 4DX.AX for alerts when major investors trade the stock.